Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioRBC Survival in Adults With Prior Antibody Response
NCT02077751Phase 1Completed
- Start
- May 2013
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Biotinylated red blood cell in anemia. Primary endpoint: Presence of biotin antibody in blood sample after transfusion of biotinylated RBCs at 6 months. Started May 2013; status: completed.
02
Drugs
Biotinylated red blood cell
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02077751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02077751.